Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Review Article

Diabetic Retinopathy: Clinical Features, Risk Factors, and Treatment Options

Author(s): Sudhanshu Mishra, Pratik Kumar Vishwakarma, Mridani Tripathi, Smriti Ojha and Shivendra Mani Tripathi*

Volume 20, Issue 7, 2024

Published on: 27 October, 2023

Article ID: e271023222871 Pages: 8

DOI: 10.2174/0115733998252551231018080419

Price: $65

Abstract

Diabetic retinopathy is a common complication of diabetes that affects the eyes and can lead to severe vision loss or blindness if left untreated. Chronic hyperglycemia destroys the blood vessels in the retina, resulting in diabetic retinopathy. The damage can lead to leakage of fluid and blood into the retina, causing edema, hemorrhages, and ischemia. A thorough evaluation by an ophthalmologist is necessary to determine the most appropriate course of treatment for each patient with diabetic retinopathy. The article discusses various surgical treatment options for diabetic retinopathy, including vitrectomy, scleral buckling, epiretinal membrane peeling, retinal detachment repair, and the risk factors of diabetic retinopathy. These surgical techniques can help to address the underlying causes of vision loss and prevent further complications from developing or worsening. To avoid complications and maintain vision, this review emphasizes the significance of early detection and treatment of diabetic retinopathy. Patients with diabetic retinopathy can improve their eyesight and quality of life with the help of some surgical treatments. The article also highlights some case studies in the field of diabetic retinopathy.

[1]
Egunsola O, Dowsett LE, Diaz R, Brent MH, Rac V, Clement FM. Diabetic Retinopathy Screening: A Systematic Review of Qualitative Literature. Can J Diabetes 2021; 45(8): 725-733.e12.
[http://dx.doi.org/10.1016/j.jcjd.2021.01.014] [PMID: 33814308]
[2]
Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: Does it really matter? Diabetologia 2018; 61(9): 1902-12.
[http://dx.doi.org/10.1007/s00125-018-4692-1] [PMID: 30030554]
[3]
Hsu CR, Chen YT, Sheu WHH. Glycemic variability and diabetes retinopathy: A missing link. J Diabetes Complications 2015; 29(2): 302-6.
[http://dx.doi.org/10.1016/j.jdiacomp.2014.11.013] [PMID: 25534877]
[4]
Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol 2003; 136(1): 122-35.
[http://dx.doi.org/10.1016/S0002-9394(03)00219-8] [PMID: 12834680]
[5]
Chakrabarti R, Harper CA, Keeffe JE. Diabetic retinopathy management guidelines. Expert Rev Ophthalmol 2012; 7(5): 417-39.
[http://dx.doi.org/10.1586/eop.12.52]
[6]
Wang W, Lo A. Diabetic retinopathy: Pathophysiology and treatments. Int J Mol Sci 2018; 19(6): 1816.
[http://dx.doi.org/10.3390/ijms19061816] [PMID: 29925789]
[7]
Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54(6): 1615-25.
[http://dx.doi.org/10.2337/diabetes.54.6.1615]
[8]
Lechner J, O’Leary OE, Stitt AW. The pathology associated with diabetic retinopathy. Vision Res 2017; 139: 7-14.
[http://dx.doi.org/10.1016/j.visres.2017.04.003] [PMID: 28412095]
[9]
Ansari P, Tabasumma N, Snigdha NN, et al. Diabetic retinopathy: An overview on mechanisms, pathophysiology and pharmacotherapy. Diabetology 2022; 3(1): 159-75.
[http://dx.doi.org/10.3390/diabetology3010011]
[10]
Rogers DG. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Clin Pediatr (Phila) 1994; 33(6): 378.
[http://dx.doi.org/10.1097/00132586-199406000-00052]
[11]
Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: The old and the new. Diabetes Metab J 2018; 42(5): 364-76.
[http://dx.doi.org/10.4093/dmj.2018.0182] [PMID: 30362302]
[12]
Kupis M, Samelska K, Zaleska-Żmijewska A, Szaflik J. Introduction to pathophysiology of diabetic retinopathy. Klin Oczna 2021; 123(2): 69-73.
[http://dx.doi.org/10.5114/ko.2021.106907]
[13]
Lim LS, et al. Lipids and diabetic retinopathy. Expert Opin Biol Ther 2012; 12(1): 93-105.
[http://dx.doi.org/10.1517/14712598.2012.641531]
[14]
Turner R. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352(9131): 854-65.
[http://dx.doi.org/10.1016/S0140-6736(98)07037-8] [PMID: 9742977]
[15]
Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998; 116(7): 874-86.
[http://dx.doi.org/10.1001/archopht.116.7.874] [PMID: 9682700]
[16]
Kuo JZ, Wong TY, Rotter JI, Wiggs JL. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol 2014; 132(1): 96-107.
[http://dx.doi.org/10.1001/jamaophthalmol.2013.5024] [PMID: 24201651]
[17]
Gaedt Thorlund M, Borg Madsen M, Green A, Sjølie AK, Grauslund J. Is smoking a risk factor for proliferative diabetic retinopathy in type 1 diabetes? Ophthalmologica 2013; 230(1): 50-4.
[http://dx.doi.org/10.1159/000350813] [PMID: 23751972]
[18]
He F, Xia X, Wu XF, Yu XQ, Huang FX. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: A meta-analysis. Diabetologia 2013; 56(3): 457-66.
[http://dx.doi.org/10.1007/s00125-012-2796-6] [PMID: 23232641]
[19]
Manao IL, Hutami HT, Rahmi FL, Saubig AN. The association of diabetes duration with the severity of diabetic retinopathy. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) 2021; 10(1): 64-8.
[http://dx.doi.org/10.14710/dmj.v10i1.29942]
[20]
Rani PK, Parameswarappa DC, Rajalakshmi R, et al. Severity of diabetic retinopathy and its relationship with age at onset of diabetes mellitus in India: A multicentric study. Indian J Ophthalmol 2021; 69(11): 3255-61.
[http://dx.doi.org/10.4103/ijo.IJO_1459_21] [PMID: 34708783]
[21]
Ezra E, Keinan E, Mandel Y, Boulton ME, Nahmias Y. Non-dimensional analysis of retinal microaneurysms: Critical threshold for treatment. Integr Biol 2013; 5(3): 474-80.
[http://dx.doi.org/10.1039/c3ib20259c] [PMID: 23371018]
[22]
Gupta A, Singh R, Ramasamy K, Abraham C, Gupta V. Diabetic retinopathy: An update. Indian J Ophthalmol 2008; 56(3): 179.
[http://dx.doi.org/10.4103/0301-4738.40355] [PMID: 18417817]
[23]
Lövestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation. Acta Ophthalmol Scand 2003; 81(3): 221-5.
[http://dx.doi.org/10.1034/j.1600-0420.2003.00050.x] [PMID: 12780397]
[24]
Takayama K, Ogawa M, Mochizuki M, Takeuchi M. Cytomegalovirus retinitis in a patient with proliferative diabetes retinopathy. Ocul Immunol Inflamm 2013; 21(3): 225-6.
[http://dx.doi.org/10.3109/09273948.2012.762983] [PMID: 23480605]
[25]
Corcóstegui B, Durán S, González-Albarrán MO, et al. Update on diagnosis and treatment of diabetic retinopathy: A consensus guideline of the working group of ocular health (Spanish society of diabetes and Spanish vitreous and retina society). J Ophthalmol 2017; 2017: 1-10.
[http://dx.doi.org/10.1155/2017/8234186] [PMID: 28695003]
[26]
Nagpal D, Panda S N, Malarvel M, Pattanaik P A, Zubair Khan M. 2022; A review of diabetic retinopathy: Datasets, approaches, evaluation metrics and future trends. J King Saud Uni - Comp Info Sci 2022; 34(11)
[http://dx.doi.org/10.1016/j.jksuci.2021.06.006]
[27]
Yadav S, Tandon R. Comprehensive eye examination: What does it mean? Community Eye Health 2019; 32(107): S1-4.
[PMID: 32123482]
[28]
Mayya V. Automated microaneurysms detection for early diagnosis of diabetic retinopathy: A Comprehensive review. Comput Methods Programs Biomed Updat 2021; 1: 100013.
[http://dx.doi.org/10.1016/j.cmpbup.2021.100013]
[29]
Vaz-Pereira S, Morais-Sarmento T, Engelbert M. Update on optical coherence tomography and optical coherence tomography angiography imaging in proliferative diabetic retinopathy. Diagnostics (Basel) 2021; 11(10): 1869.
[http://dx.doi.org/10.3390/diagnostics11101869]
[30]
Das D, Biswas SK, Bandyopadhyay S. A critical review on diagnosis of diabetic retinopathy using machine learning and deep learning. Multimedia Tools Appl 2022; 81(18): 25613-55.
[http://dx.doi.org/10.1007/s11042-022-12642-4] [PMID: 35342328]
[31]
Haydinger CD, Ferreira LB, Williams KA, Smith JR. Mechanisms of macular edema. Front Med (Lausanne) 2023; 10: 1128811.
[http://dx.doi.org/10.3389/fmed.2023.1128811]
[32]
Barth T, Helbig H. Diabetisches Makulaödem. Klin Monatsbl Augenheilkd 2021; 238(9): 1029-43.
[http://dx.doi.org/10.1055/a-1545-9656] [PMID: 34380156]
[33]
Biletskaya VA, Lipatov DV, Frolov MA, Kazakova KA. Neovascular glaucoma in patients with diabetes mellitus — the current state of the problem. Diabetes mellitus 2021; 24(4): 357-64.
[http://dx.doi.org/10.14341/DM12490]
[34]
Kameda Y, Hanai K, Uchigata Y, Babazono T, Kitano S. Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis. J Diabetes Investig 2020; 11(3): 688-92.
[http://dx.doi.org/10.1111/jdi.13161] [PMID: 31618517]
[35]
Almaliky A, Mansoor H, Alabbood M. Higher prevalence of diabetes mellitus among patient with nonarteritic ischemic optic neuropathy. Iraqi National Journal of Medicine 2022; 4(1): 24-30.
[http://dx.doi.org/10.37319/IQNJM.4.1.3]
[36]
Rees G, Xie J, Fenwick EK, et al. Association between diabetes-related eye complications and symptoms of anxiety and depression. JAMA Ophthalmol 2016; 134(9): 1007-14.
[http://dx.doi.org/10.1001/jamaophthalmol.2016.2213] [PMID: 27387297]
[37]
Rossi T, Panozzo G, Della Mura G, et al. Diabetes and diabetic retinopathy in patients undergoing cataract surgery: A prevalence study—DiCat study report #2. Acta Diabetol 2020; 57(6): 645-50.
[http://dx.doi.org/10.1007/s00592-019-01466-8] [PMID: 31912329]
[38]
Doft BH, Wisniewski SR, Kelsey SF, Fitzgerald SG. Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol 2001; 119(5): 650-6.
[http://dx.doi.org/10.1001/archopht.119.5.650] [PMID: 11346391]
[39]
Lam WC, Wong AMF, Chen J. Scleral ectasia in rhegmatogenous retinal detachment. Can J Ophthalmol 1996; 31(5): 241-4.
[PMID: 8872376]
[40]
Mayer EJ, Hughes EH, Carter DA, Dick AD. Nestin positive cells in adult human retina and in epiretinal membranes. Br J Ophthalmol 2003; 87(9): 1154-8.
[http://dx.doi.org/10.1136/bjo.87.9.1154] [PMID: 12928287]
[41]
Nilforushan N, Es’haghi A, Miraftabi A, Abolfathzadeh N, Banifatemi M. Trabeculectomy in patients with diabetes: Subconjunctival Mitomycin C with or without intravitreal bevacizumab. Br J Ophthalmol 2022; 106(5): 648-54.
[http://dx.doi.org/10.1136/bjophthalmol-2020-317324] [PMID: 33328187]
[42]
Ebrahimi MH, Gharibi H. A case study of a patient with diabetic retinopathy. Diabetes Metab Syndr 2016; 10(3): 166-8.
[http://dx.doi.org/10.1016/j.dsx.2016.01.022] [PMID: 26907970]
[43]
Kohmoto R, Kobayashi T, Sato T, et al. A case of proliferative diabetic retinopathy in which scintillating particles appeared in the intravitreal cavity after laser photocoagulation. BMC Ophthalmol 2017; 17(1): 254.
[http://dx.doi.org/10.1186/s12886-017-0654-5] [PMID: 29258460]
[44]
UpToDate Interactive diabetes case 13: Deterioration of glycemia in a 59-year-old patient with type 2 diabetes complicated by retinopathy, nephropathy, and neuropathy. 2023. Available from: https://www.uptodate.com/contents/interactive-diabetes-case-13-deterioration-of-metabolic-control-in-a-59-year-old-patient-with-type-2-diabetes-complicated-by-retinopathy-nephropathy-and-neuropathy
[45]
Raka M, Daigavhane S, Patil A. A clinical case report of diabetic retinopathy. Asian J Biomed Pharm Sci 2022; 12(90): 128.
[46]
Jessie NIM. Proliferative Diabetic Retinopathy in a 16-year-old – A case report. Zambia: The Health Press 2020.
[47]
Nishikawa Y, Morishita S, Nakamura K, et al. Two cases of proliferative diabetic retinopathy with marked sheathing of the retinal arteries following vitrectomy. Case Rep Ophthalmol 2017; 8(1): 40-8.
[http://dx.doi.org/10.1159/000456027] [PMID: 28413403]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy